W
ithin 3D tissues, cells must coordinate remodeling in response to stress or growth signals, and this communication may occur by direct contact or by secreted signaling molecules. Cardiac hypertrophy is a physiological response that enables the heart to adapt to an initial stress; however, hypertrophy can ultimately lead to the deterioration in cardiac function and an increase in cardiac arrhythmias (1) . Although considerable progress has been made in elucidating the molecular pathogenesis of cardiac hypertrophy, the precise mechanisms guiding the hypertrophic process remain unknown. Recent evidence suggests that myocardial heparin-binding (HB)-epidermal growth factor participates in the hypertrophic response (2, 3) . In cardiomyocytes, hypertrophic stimuli markedly increase expression of the HB-EGF gene (4) , suggesting that HB-EGF can act as an autocrine trophic factor that contributes to cellular growth. HB-EGF is first synthesized as a membrane-anchored form (proHB-EGF), and subsequent ectodomain shedding at the cell surface releases the soluble form of HB-EGF. Soluble HB-EGF is a diffusible factor that can be captured by the receptors to activate the intracellular EGF receptor signaling cascade. Indeed, EGF receptor (EGFR) transactivation, triggered by shedding of HB-EGF from the cell surface, plays an important role in cardiac hypertrophy resulting from pressure overload in the aortic-banding model (3) .
EGFR activation can occur through autocrine and paracrine signaling. In autocrine signaling, a cell produces and responds to the same signaling molecules. Paracrine signaling molecules can target groups of distant cells or act as localized mediators affecting only cells in the immediate environment of the signaling cell. Thus, although locally produced HB-EGF may travel through the extracellular space, it may also be recaptured by the EGFR close to the point where it was released from the cell surface (5, 6) . The impact of spatially localized microenvironments of signaling could be extensive heterogeneous tissue remodeling, which can be particularly important in an electrically coupled tissue like myocardium. Interestingly, recent data suggest that EGF can regulate proteasome-dependent degradation of connexin43 (Cx43), a major transmembrane gap junction protein, in liver epithelial cells (7) , along with a rapid inhibition of cell-cell communication through gap junctions (8) . One of the critical potential myocardial effects of HB-EGF could therefore be to increase degradation of Cx43 and reduce electrical stability of the heart. Reduced content of Cx43 is commonly observed in chronic heart diseases such as hypertrophy, myocardial infarction, and failure (9, 10) .
Thus, we hypothesized that HB-EGF signals may operate in a spatially restricted local circuit in the extracellular space. We also hypothesized that HB-EGF secretion by a given cardiomyocyte could create a local remodeling microenvironment of decreased Cx43 within the myocardium. To explore whether HB-EGF signaling is highly spatially constrained, we took advantage of the nonuniform gene transfer to cardiac myocytes in vivo, normally considered a pitfall of gene therapy. We also performed computational modeling to predict HB-EGF dynamics and developed a 3D approach to measure cardiomyocyte hypertrophy.
Materials and Methods
Materials. Reagents included a polyclonal antibody against HB-EGF (Oncogene Research Products), a mouse monoclonal antiCx43 antibody (CXN-6, Sigma), an anti-Actin antibody (Sigma), a polyclonal antibody against N-cadherin H-63 (Santa Cruz Biotechnology), rabbit polyclonal antibodies to extracellular signalregulated kinase (ERK)1͞2 and phospho-ERK1͞2 (Thr-202͞Tyr-204) (Cell Signaling Technology, Beverly, MA), Isolectin IB4 Alexa Fluor 568 conjugate (Molecular Probes), and Tyrphostin AG 1478 (Calbiochem).
HB-EGF (GenBank accession no. NM010415). Recombinant adenoviral constructs expressing HB-EGF (Ad-HB-EGF) in tandem with constitutive GFP were generated by using the AdEasy Adenoviral Vector System (Stratagene). For controls, we used the identical virus vector expressing GFP alone (Ad-GFP). (15) . Briefly, male FVB mice (age 10 to 12 weeks) were anesthetized with pentobarbital (30 g͞g i.p.) and adenoviral vectors (Ad-GFP or Ad-HB-EGF) were directly injected into the left ventricular free walls (2 ϫ 10 9 plaqueforming units in 50 l). At 7 days after surgery, mouse hearts were harvested and fixed with 4% paraformaldehyde. Myocytes were grouped as infected or noninfected by comparing the brightfield images with fluorescent images looking for GFP expression. This approach allowed assessment of cell size and identification of infected cells with the gene transfer vector. All surgeries were performed in a blinded and randomized manner with respect to virus type. The Harvard Medical School Standing Committee on Animal Research approved the study protocols.
Three-Dimensional Histology. Mouse hearts were labeled by using a Texas red-maleimide (Molecular Probes) tail vein injection, followed by removing the heart, fixing with 4% paraformaldehyde and embedding in paraffin. Five-micrometer slices were cut and plated on glass slides for a total of 200 slices. Every other slice was imaged at 10ϫ by using an Olympus IX70 inverted fluorescence microscope by using both red (ex545͞15 and em620͞30) and green (ex480͞20 and em535͞25) filter sets to image the maleimide staining and detect the presence of GFP in the cells. Postprocessing was performed first by aligning images based on identical physical features in successive slices, extracting single myocytes by using the maleimide stain as the borders of the cells, and then adding the successive cross-sectional areas and multiplying by the spacing between slices (10 m because every other slice was omitted) to obtain the cell volume. Postprocessing was performed blinded to virus type to avoid bias. Positive Cx43 and N-cadherin staining per tissue area were quantified in MATLAB for green areas (virus infected), adjacent areas, and remote areas. Adjacent areas are defined as those within an 18-m radius of the virus-infected cell. Data from each heart was normalized with Cx43͞N-cadherin staining per remote area data to account for variations in the heart fixation conditions. Remote area images are of intact tissue far from the site of injection or virus infection.
Computational Modeling and Statistical Analysis. Model equations were solved numerically in FEMLAB 3 (Comsol, London) subject to boundary conditions and the defined tissue geometry at steady state. All data are presented as mean Ϯ SEM. Statistical analysis was performed with the two-tailed unpaired Student t test, MannWhitney rank sum test, or one-way ANOVA for multiple comparisons with the Tukey-Kramer method. Statistical significance was achieved when P Ͻ 0.05.
Results
Autocrine HB-EGF and Cardiomyocyte Growth. To assess the effects of gene transfer of HB-EGF on cardiomyocyte hypertrophy, cells were infected with adenoviral vectors expressing GFP alone (Ad-GFP) or HB-EGF and GFP (Ad-HB-EGF) at an moi of 80 for 3 h and incubated in serum-free conditions for Ϸ72 h. At this level of infection, 99% of cardiomyocytes were transduced. The incidence of apoptotic cell death (sub-G 1 fraction) was not different between Ad-GFP cells (5.4 Ϯ 0.5%, n ϭ 3) and noninfected control cells (5.9 Ϯ 0.6%, n ϭ 3, P ϭ not significant), suggesting that expression of GFP by the adenoviral vector was not cardiotoxic in these conditions. Western analysis by using an anti-HB-EGF antibody confirmed successful gene transfer of HB-EGF in cardiomyocytes (18 Ϯ 5-fold, n ϭ 4, P Ͻ 0.01); HB-EGF appeared electrophoretically as several bands from 15 to 30 kDa (Fig. 1A) . The strongest band corresponds to the soluble 20-kDa form of HB-EGF. To confirm that Ad-HB-EGF results in cellular hypertrophy, cell size and protein synthesis were measured. Ad-HB-EGF enlarged cardiomyocytes compared with Ad-GFP-infected cells by phasecontrast microscopy (24 Ϯ 10% increase in cell surface area, n ϭ 27, P Ͻ 0.05) and with flow cytometry analysis (26 Ϯ 10% increase of Ad-GFP infected cells, P Ͻ 0.01, Fig. 1B ). Overexpression of HB-EGF increased total protein synthesis in cardiomyocytes as measured by [ 3 H]leucine uptake (34 Ϯ 6% of Ad-GFP, n ϭ 6, P Ͻ 0.01, Fig. 1C ). Uninfected cells within the same dish (and thus sharing the same culture media) did not develop hypertrophy. Additionally, medium from cultures previously infected with Ad-HB-EGF for 48 h was collected and applied to adenovirus-free cultures. Conditioned medium from Ad-HB-EGF-infected cardiomyocytes failed to stimulate hypertrophy in naive cardiomyocytes (Fig. 1C) , and there were no significant differences in cell size between noninfected cells from Ad-GFP and Ad-HB-EGF dishes. These results suggest that HB-EGF acts primarily as an autocrine growth factor in cardiomyocytes in vitro.
Because the dilution factor in culture media is important for autocrine͞paracrine signaling, we determined the concentration of soluble HB-EGF in the conditioned medium and the effective concentration to stimulate cardiomyocyte growth. HB-EGF levels in the conditioned medium from Ad-HB-EGF dishes were 258 Ϯ 73 pg͞ml (n ϭ 4), whereas HB-EGF levels from Ad-GFP dishes (n ϭ 8) were below the limit of detection (6.7 pg͞ml). The addition of 300 pg͞ml of exogenous recombinant HB-EGF into fresh media failed to stimulate hypertrophy in cardiomyocytes as measured by [ 3 H]leucine uptake (Ϫ12 Ϯ 5.0% compared with control, n ϭ 5, P ϭ not significant), but 2,000 pg͞ml of recombinant HB-EGF did result in a significant effect (ϩ24 Ϯ 5.5% compared with control, n ϭ 6, P Ͻ 0.05). This comparison implies that the local concentration of autocrine ligand is substantially greater than that indicated by a bulk measurement of conditioned media, consistent with previous experimental and theoretical studies (5, 6).
Effects of HB-EGF on Cx43 Content in Cultured Cardiomyocytes.
Because EGF can induce degradation of the gap junction protein Cx43 in other cells (7), we then determined whether Cx43 is regulated by HB-EGF in cardiomyocytes. Fig. 2A shows a representative immunoblot from three separate experiments in which Cx43 migrated as three major bands at 46, 43, and 41 kDa, as reported in ref. 16 . Overexpression of HB-EGF decreased total Cx43 content (27 Ϯ 11% compared with Ad-GFP, n ϭ 4, P Ͻ 0.05) without affecting the intercellular adhesion protein, N-cadherin. The phosphorylation of ERK1͞2, an intracellular signaling kinase downstream of EGFR transactivation, was augmented by HB-EGF (3.2 Ϯ 1.0-fold compared with Ad-GFP, n ϭ 4, P Ͻ 0.05). Northern analysis showed that HB-EGF did not reduce Cx43 gene expression, suggesting that HB-EGF decreases Cx43 by posttranslational modification (Fig. 2B) . AG 1478 (10 M), a specific inhibitor of EGFR tyrosine kinase, abolished the effect of HB-EGF on Cx43 (Fig. 2C) , indicating that the decrease in Cx43 content depends on EGFR transactivation by HB-EGF. The conditioned medium from Ad-HB-EGF-infected cells did not change expression of Cx43 in naive cells, even though ERK1͞2 was slightly activated by the conditioned medium (Fig. 1D) . These data are consistent with the hypertrophy data presented above, demonstrating that HB-EGF can act as a predominantly autocrine factor both in hypertrophy and in the reduction of Cx43 content in cardiomyocytes.
Computational Analysis Predicts HB-EGF Autocrine͞Paracrine Signaling in Vivo. Although these in vitro experiments showed HB-EGF as a predominantly autocrine cardiac growth factor, HB-EGF signaling in vivo takes place in a very different environment. Therefore, we sought to determine the extent that soluble HB-EGF may travel in the interstitial space of the myocardium with a simple 2D model of HB-EGF diffusion (Fig. 3A ). An approximate geometric representation of myocytes in cross-section is a square (15 ϫ 15 m), with each of the corners occupied by a capillary (diameter 5 m). The cell shape was chosen so that the extracellular matrix width (0.5 m), in which soluble HB-EGF is free to diffuse, was constant around all tissue features. This model geometry is based on a square array of capillaries; although a hexagonal pattern of capillary distribution is commonly accepted, the results are not expected to be substantially different with this simpler construction, because both have four capillaries surrounding each myocyte.
The model represents a single central cell that is releasing HB-EGF at a constant rate, R gen , (approximated from the HB-EGF concentration measurement in conditioned medium) into the extracellular space. HB-EGF then can diffuse throughout this space, or enter a capillary and leave the system. This system is governed by the diffusion equation at steady state (D… 2 C ϭ 0), the boundary condition for the ligand producing cell (ϪD…C ϭ R gen ), the boundary condition for all other cells (ϪD…C ϭ 0), and the capillary boundary condition (D…C ϭ h(C Ϫ C blood )). C denotes HB-EGF concentration, D is the diffusivity constant, h is the mass transfer coefficient, and C blood is the concentration of HB-EGF in the blood, approximated to be zero.
The numerical solution in Fig. 3B illustrates that HB-EGF remained localized around the cell which produced it and did not diffuse farther because of the sink-like effect of the capillaries. The maximum concentration of soluble HB-EGF achieved is 0.27 nM, which is near the threshold level of HB-EGF measured to stimulate cardiomyocyte growth (2,000 pg͞ml). Therefore, the central HB-EGF-producing cell only signals to its four adjacent neighbors where the HB-EGF concentration reaches this threshold. However, if the model geometry is altered to reflect a 50% and 150% increase in cross-sectional area in all cells because of hypertrophy, estimated from 1 and 4 weeks of transverse aortic constriction (15, 17) , the maximum concentration achieved increases slightly to 0.29 nM and 0.37 nM, respectively. As the cell width increases, HB-EGF must diffuse farther to reach a capillary, exposing adjacent cells to a higher concentration during hypertrophy. However, no additional cells are exposed to HB-EGF.
The driving force that determined the extent to which HB-EGF traveled was the rate of HB-EGF transfer into the capillaries and the diffusivity of HB-EGF. The exact mechanism of macromolecule transport into capillaries is unknown (18) ; however, it is most likely through diffusion, transcytosis, or a combination of the two. In the case of diffusion, the mass transfer coefficient governing the flux of HB-EGF through the capillary wall is coupled to the diffusivity of HB-EGF, whereas the terms are uncoupled for the case of transcytosis. Therefore, this model assessed transcytosis as a conservative scenario for HB-EGF localization. Parameter perturbation with uncoupled diffusion and capillary mass transfer showed that HB-EGF remained localized around the origin of production and diffused only to immediate neighbors for mass transfer coefficients Ͼ0.002 m͞s. For values Ͻ0.002 m͞s, HB-EGF diffused distances more than two cells away from the origin. Although the actual mass transfer coefficient of ligands in the size range of HB-EGF is unknown, values for O 2 (0.02 m͞s, 0.032 kDa) (19) and LDL (1.7 ϫ 10 Ϫ5 m͞s, 2,000-3,000 kDa) (20) have been reported, and we assumed HB-EGF is in the upper end of that range due to its small size. HB-EGF also binds to EGFRs, the extracellular matrix, and cell surface heparan sulfate proteoglycans. EGFR binding and internalization could serve to further localize HB-EGF. The number of extracellular binding sites does not affect the steady-state HB-EGF concentration profile if this binding is reversible. However, these binding sites could serve to localize HB-EGF as the cell begins to produce the ligand by slowing the travel of HB-EGF to the capillaries in the approach to the steady state, or as a source of HB-EGF as the cell slows or stops HB-EGF production. At a diffusivity of 0.7 m 2 ͞s (21), HB-EGF traveled only one cell away, but traveled approximately five cells away at 51.8 m 2 ͞s (22), with a peak concentration below the estimated threshold for stimulating hypertrophy. Thus, the model predicts that HB-EGF is a highly localized autocrine and paracrine growth factor within the myocardium.
Overexpression of HB-EGF Causes Hypertrophy on the Infected Cell and Its Immediate Neighbor in Vivo.
To explore whether HB-EGF signals operate in a spatially restricted local circuit in the in vivo myocardial extracellular space as predicted by computational modeling, adenoviral vectors were injected directly into the left ventricular free wall in 26 male mice (Ad-GFP, n ϭ 12; Ad-HB-EGF, n ϭ 14). Of the 26 mice, 5 (4 Ad-GFP and 1 Ad-HB-EGF) mice died after the surgery. Gene expression was confirmed as positive cellular fluorescence in the presence of GFP, allowing determination of which cells were infected at 7 days (Fig. 4A) . Immunohistochemical staining revealed that HB-EGF was localized on the Ad-HB-EGF-infected cell membrane or in the extracellular space around the overexpressing cell (Fig. 4A) . For comparison, remote cells were defined as noninfected cells far (15-20 cell dimensions) from the adenovirus-infected area and in the same field as infected cells. Conventional 2D cross-sectional analysis blinded to treatment group (Fig. 4B) showed that Ad-GFP-infected cells (n ϭ 102) resulted in no cellular hypertrophy compared with noninfected, adjacent (n ϭ 92), or remote (n ϭ 97) cells (2D myocyte crosssectional area, 250 Ϯ 7 versus 251 Ϯ 7 or 255 Ϯ 6 m 2 , respectively). These data suggest that expression of GFP in these conditions does not cause cellular hypertrophy. However, overexpression of HB-EGF caused hypertrophy in both Ad-HB-EGF-infected cells (a 41 Ϯ 5% increase of Ad-GFP-infected cells, n ϭ 119, P Ͻ 0.01) and noninfected adjacent cells (a 33 Ϯ 5% increase of Ad-GFP-adjacent cells, n ϭ 97, P Ͻ 0.01) compared with remote cells (n ϭ 109). Because 2D analysis of cardiomyocyte hypertrophy can be influenced by the plane of sectioning, we then developed a 3D histology approach that allowed reconstruction of cardiomyocytes in situ (Fig.  4C) . We performed an independent 3D histology analysis of cardiomyocytes to determine cell volumes, blinded to treatment group (Fig. 4B) . The volumes of both HB-EGF-infected cells (n ϭ 19, 42,700 Ϯ 4,000 m 3 ) and their adjacent cells (n ϭ 11, 33,500 Ϯ 3,300 m 3 ) were significantly greater than volumes of remote cells (n ϭ 13, 18,600 Ϯ 1,700 m 3 , P Ͻ 0.01 vs. HB-EGF-infected cells and P Ͻ 0.05 vs. HB-EGF-adjacent cells, Fig. 4D ). In contrast, cells treated with Ad-GFP (n ϭ 12) showed no hypertrophy in the Ad-GFP-adjacent (n ϭ 10) or remote cells (n ϭ 9). These data demonstrate that HB-EGF acts as both an autocrine and local paracrine growth factor within myocardium, as predicted by computational modeling.
Degradation of Cx43 Through Local Autocrine͞Paracrine HB-EGF.
To determine whether the spatially confined effect of HB-EGF reduces local myocardial Cx43 in vivo, Cx43 was assessed with immunohistochemistry and confocal f luorescence imaging. Cells infected with Ad-HB-EGF had significant decreases in Cx43 immunoreactive signal compared with Ad-GFP cells, consistent with the results of in vitro immunoblotting (Fig. 5A) . Quantitative digital image analyses of Cx43 in a total of 22 fields in 6 Ad-HB-EGF hearts and 19 fields in 4 Ad-GFP hearts were analyzed (Fig. 5B) . Although Ad-GFP-infected cells showed immunoreactive Cx43 at the appositional membrane, overexpression of HB-EGF increased Cx43 in intracellular vesicle-like components (Fig. 5C) , with reduced gap junction plaques (percent Cx43 area per cell area, 52 Ϯ 8% of Ad-GFP control, P Ͻ 0.01). These data suggest that reduced expression of Cx43 can be attributed to an increased rate of internalization and degradation in gap junction plaques in cardiomyocytes. Interestingly, HB-EGF secretion by a given cardiomyocyte caused a 37 Ϯ 13% reduction of Cx43 content in its adjacent cells compared with GFP controls (P Ͻ 0.05). As degradation of Cx43 may accompany structural changes with marked rearrangement of intercellular connections, we also The maximum concentration achieved with the stated parameters was 0.27 nM from a capillary. Myocyte length was assumed to be 100 m.
explored whether the intercellular adhesion protein, Ncadherin, was affected by overexpression of HB-EGF. In contrast to Cx43, there was no significant difference in total area occupied by N-cadherin immunoreactive signal in between Ad-GFP (n ϭ 19) and Ad-HB-EGF hearts (1.8 Ϯ 0.5-fold compared with Ad-GFP, n ϭ 17, P ϭ not significant), indicating that HB-EGF has a selective effect on Cx43. Taken together, these data show that HB-EGF leads to cardiomyocyte hypertrophy and degradation of Cx43 in the infected cell and its immediately adjacent neighbors because of autocrine͞ paracrine signaling. It should be noted, however, that quantifying the Cx43 from immunostaining could be limited by a nonlinear relation between the amount of Cx43 present and the area of staining.
Discussion
We have demonstrated in this study that HB-EGF secreted by cardiomyocytes leads to cellular growth and reduced expression of the principal ventricular gap junction protein Cx43 in a local autocrine͞paracrine manner. Although proHB-EGF is biologically active as a juxtacrine growth factor that can signal to immediately neighboring cells in a nondiffusible manner (23- 25), several studies have revealed the crucial role of metalloproteases in the enzymatic conversion of proHB-EGF to soluble HB-EGF, which binds to and activates the EGFR. Hypertrophic stimuli such as mechanical strain (26) and G protein-coupled receptors agonists (3) mediate cardiac hypertrophy through the shedding of membrane-bound proHB-EGF. Thus, an autocrine͞paracrine loop, which requires the diffusible, soluble form of HB-EGF, is necessary for subsequent transactivation of the EGFR to produce the hypertrophic response.
To our knowledge, there have been no previous reports concerning the spatial extent of autocrine͞paracrine ligand distribution and signaling in myocardial tissue. A theoretical analysis by Shvartsman et al. (6) predicted, from computational modeling in an idealized cell culture environment, that autocrine ligands may remain highly localized, even within subcellular distances; this prediction has support from experimental data in the EGFR system (5). In contrast, a theoretical estimate by Francis and Palsson (27) has suggested that cytokines might effectively communicate larger distances, approximated to be Ϸ200-300 m from the point of release. However, these studies have all focused on idealized cell culture systems, so our combined experimental and computational investigation here aimed at understanding both in vitro and in vivo situations offers insight.
Our computational model of diffusion in the extracellular space predicts that HB-EGF acts as both an autocrine and spatially restricted paracrine growth factor for neighboring cells. We studied the responses of the signaling cell and its immediate neighbors compared with more distant cells. For a paracrine signal to be delivered to its proper target, the secreted signaling molecules cannot diffuse too far; in vitro experiments, in fact, indicated that HB-EGF acts as a predominantly autocrine signal in cell culture, where diffusion into the medium is relatively unconstrained.
In contrast, in the extracellular space of the myocardium, HB-EGF is localized around the source of production because of tissue geometry, thereby acting in a local paracrine or autocrine manner only. Indeed, our results from in vivo gene transfer demonstrated that both the cell releasing soluble HB-EGF and its surrounding cells undergo hypertrophy. This localized conversation between neighboring cells may allow remodeling to be fine-tuned on a highly spatially restricted level within the myocardium and in other tissues.
Conventional 2D histology gives a different cross section of the myocyte depending on sectioning plane, and a given cell may be affected by a cell that is out-of-plane. For example, in our study, a myocyte could have appeared to have no contacts with an HB-EGF overexpressing cell, whereas in another section, one or more adjacent cells could be cells overexpressing HB-EGF. Therefore, we developed a 3D imaging method that is capable of showing relative cell position and rotation and provides substantial confidence in our analysis. Although it has been reported that transgenic expression of GFP can cause eccentric hypertrophy and dilated cardiomyopathy (28) , shorter expression of GFP alone by adenoviral gene transfer did not cause any significant changes in cell volume in our study. In contrast, cells overexpressing HB-EGF and their adjacent cells were significantly larger than remote cells. Interestingly, the increase in 3D volume was greater than the increase in 2D cross-sectional area, suggesting that the increase in cardiomyocyte size occurs in all three dimensions.
We speculate that localized remodeling that requires one cell to move relative to its neighbor may require at least transient breakdown of Cx43 gap junctions between those two cells. Previous studies have shown that EGF down-regulates Cx43 expression in cultured rat cortical astrocytes (29) . EGF-induced phosphorylation of Cx43 induces binding of ubiquitin and targets Cx43 for internalization and degradation in a proteasomedependent manner in liver epithelial cells (7) . Although the specific intracellular signal transduction pathways responsible for the effects of HB-EGF on Cx43 expression in cardiomyocytes remain unclear, our results demonstrate that Cx43 is internalized and degraded in the HB-EGF-overexpressed cell and its neighbors. Interestingly, a computer simulation found that a 40-60% reduction in junctional conductance results in only moderate changes in conduction velocity even when cell size was increased by 50% (30, 31) . In a diseased heart, however, Cx43 expression can be heterogeneous, e.g., HB-EGF can create microenvironments with some regions that have a virtually normal density of Cx43 expression, whereas other regions lack Cx43 almost completely. Thus, the local disruption in gap junctions that may be a part of the hypertrophic response induced by autocrine͞ paracrine HB-EGF could give rise to potential heterogeneous effects on electrical propagation in hypertrophied or remodeling hearts.
In conclusion, HB-EGF acts as a local mediator, affecting cardiomyocytes in the immediate environment of the signaling cell within the myocardium. The orchestrated regulation of cell-cell communication by HB-EGF dynamics in local autocrine͞paracrine signaling provides insights into how an intercellular network integrally operates the hypertrophic process in the heart.
